Search

everythinglearnresearchcommunity

for

Search:↓

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Frontal Fibrosing Alopecia might be an autoimmune disease.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

SLE and DM can coexist but are rare and need careful evaluation.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Selective breeding can enhance immunity in dairy cattle.

Many children with alopecia areata also have other autoimmune diseases.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.